Jenoptik Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Jenoptik wird ein jährliches Gewinn- und Umsatzwachstum von 12.3% bzw. 4.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 12.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.6% betragen.

Wichtige Informationen

12.3%

Wachstumsrate der Gewinne

12.2%

EPS-Wachstumsrate

Electronic Gewinnwachstum	41.1%
Wachstumsrate der Einnahmen	4.4%
Zukünftige Eigenkapitalrendite	11.6%
Analystenabdeckung	Good
Zuletzt aktualisiert	20 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 15

Recent updates

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 15

Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Nov 14

Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet

Jun 12

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

May 30

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35

Apr 25

Jenoptik AG's (ETR:JEN) P/E Is On The Mark

Apr 15

Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's

Mar 30

At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Mar 22

Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult

Jan 07

Is Jenoptik (ETR:JEN) A Risky Investment?

Dec 20

Why Jenoptik AG (ETR:JEN) Could Be Worth Watching

Dec 05

Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Sep 01

Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?

Aug 11

Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

Jul 25

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30

May 07

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Apr 04

Should You Think About Buying Jenoptik AG (ETR:JEN) Now?

Feb 19

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Dec 06

What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?

Nov 13

Is Jenoptik AG (ETR:JEN) Trading At A 27% Discount?

Oct 28

Is Jenoptik (ETR:JEN) A Risky Investment?

Sep 02

When Should You Buy Jenoptik AG (ETR:JEN)?

Aug 13

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

May 19

Is Now An Opportune Moment To Examine Jenoptik AG (ETR:JEN)?

May 01

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Feb 14

Is It Time To Consider Buying Jenoptik AG (ETR:JEN)?

Jan 23

Is Jenoptik (ETR:JEN) Using Too Much Debt?

Nov 07

At €32.08, Is It Time To Put Jenoptik AG (ETR:JEN) On Your Watch List?

Oct 23

Here's What To Make Of Jenoptik's (ETR:JEN) Decelerating Rates Of Return

Sep 23

Estimating The Fair Value Of Jenoptik AG (ETR:JEN)

Aug 28

Is Jenoptik (ETR:JEN) Using Too Much Debt?

Jul 27

Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Jul 13

The Returns On Capital At Jenoptik (ETR:JEN) Don't Inspire Confidence

May 17

Calculating The Intrinsic Value Of Jenoptik AG (ETR:JEN)

May 04

Jenoptik's (ETR:JEN) Conservative Accounting Might Explain Soft Earnings

Apr 01

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Mar 27

Here's What Jenoptik AG's (ETR:JEN) Shareholder Ownership Structure Looks Like

Mar 14

Is Jenoptik AG (ETR:JEN) The Right Choice For A Smart Dividend Investor?

Mar 02

Investors Who Bought Jenoptik (ETR:JEN) Shares Five Years Ago Are Now Up 140%

Feb 17

Gewinn- und Umsatzwachstumsprognosen

XTRA:JEN - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,204	117	105	189	7
12/31/2025	1,140	96	97	181	9
12/31/2024	1,117	92	52	155	9
9/30/2024	1,112	84	100	190	N/A
6/30/2024	1,102	80	102	184	N/A
3/31/2024	1,088	76	69	155	N/A
12/31/2023	1,066	73	79	167	N/A
9/30/2023	1,051	70	72	154	N/A
6/30/2023	1,038	68	69	152	N/A
3/31/2023	1,006	70	87	170	N/A
12/31/2022	981	62	63	143	N/A
9/30/2022	929	75	56	130	N/A
6/30/2022	869	81	48	113	N/A
3/31/2022	809	91	38	92	N/A
12/31/2021	751	91	52	98	N/A
9/30/2021	630	69	56	101	N/A
6/30/2021	616	58	47	89	N/A
3/31/2021	602	37	48	87	N/A
12/31/2020	615	33	46	90	N/A
9/30/2020	765	48	69	113	N/A
6/30/2020	801	54	94	143	N/A
3/31/2020	836	57	84	136	N/A
12/31/2019	855	68	64	109	N/A
9/30/2019	837	78	43	90	N/A
6/30/2019	833	78	47	91	N/A
3/31/2019	829	82	75	118	N/A
12/31/2018	835	88	94	135	N/A
9/30/2018	814	82	81	119	N/A
6/30/2018	784	83	N/A	97	N/A
3/31/2018	774	80	N/A	95	N/A
12/31/2017	748	73	N/A	96	N/A
9/30/2017	719	62	N/A	94	N/A
6/30/2017	706	55	N/A	107	N/A
3/31/2017	690	56	N/A	103	N/A
12/31/2016	685	54	N/A	100	N/A
9/30/2016	674	51	N/A	108	N/A
6/30/2016	679	51	N/A	102	N/A
3/31/2016	681	48	N/A	101	N/A
12/31/2015	669	49	N/A	85	N/A
9/30/2015	658	46	N/A	69	N/A
6/30/2015	623	40	N/A	72	N/A
3/31/2015	599	39	N/A	53	N/A
12/31/2014	590	38	N/A	46	N/A
9/30/2014	588	42	N/A	56	N/A
6/30/2014	600	45	N/A	37	N/A
3/31/2014	605	44	N/A	41	N/A
12/31/2013	600	44	N/A	61	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: JENDas prognostizierte Gewinnwachstum (12.3% pro Jahr) liegt über der Sparquote (1%).

Ertrag vs. Markt: JENDie Erträge des Unternehmens (12.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (21% pro Jahr).

Hohe Wachstumserträge: JENDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: JENDie Einnahmen des Unternehmens (4.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (5.6% pro Jahr).

Hohe Wachstumseinnahmen: JENDie Einnahmen des Unternehmens (4.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: JENDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.6%).

Jenoptik Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Price target decreased by 8.4% to €32.16

Price target increased by 8.5% to €33.30

Price target increased by 8.4% to €32.20

Price target decreased to €31.00

Consensus EPS estimates increase to €1.45

Recent updates

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Price target decreased by 8.4% to €32.16

Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Dividend sustainability

Investor sentiment deteriorates as stock falls 17%

Jenoptik AG to Report Fiscal Year 2024 Results on Feb 12, 2025

Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?

Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?

Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of €0.35 per share

Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

First quarter 2024 earnings released: EPS: €0.27 (vs €0.21 in 1Q 2023)

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35

Jenoptik AG's (ETR:JEN) P/E Is On The Mark

Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's

Dividend increased to €0.35

At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult

Jenoptik AG to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Is Jenoptik (ETR:JEN) A Risky Investment?

Jenoptik AG, Annual General Meeting, Jun 18, 2024

Jenoptik AG to Report Fiscal Year 2023 Results on Feb 07, 2024

Why Jenoptik AG (ETR:JEN) Could Be Worth Watching

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?

Second quarter 2023 earnings released: EPS: €0.34 (vs €0.40 in 2Q 2022)

Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

Upcoming dividend of €0.30 per share at 1.0% yield

First quarter 2023 earnings released: EPS: €0.21 (vs €0.055 in 1Q 2022)

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Should You Think About Buying Jenoptik AG (ETR:JEN) Now?

Price target increased by 8.5% to €33.30

Price target increased by 8.4% to €32.20

Jenoptik AG to Report Q1, 2023 Results on May 11, 2023

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Jenoptik AG, Annual General Meeting, Jun 07, 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Jenoptik AG (ETR:JEN) Trading At A 27% Discount?

Jenoptik AG to Report Fiscal Year 2022 Results on Feb 15, 2023

Is Jenoptik (ETR:JEN) A Risky Investment?

When Should You Buy Jenoptik AG (ETR:JEN)?

Second quarter 2022 earnings: EPS exceeds analyst expectations

Price target decreased to €31.00

STAR Capital Partnership LLP completed the acquisition of VINCORION from Jenoptik AG (XTRA:JEN).

Investor sentiment deteriorated over the past week

Upcoming dividend of €0.25 per share

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

First quarter 2022 earnings: EPS misses analyst expectations

Is Now An Opportune Moment To Examine Jenoptik AG (ETR:JEN)?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Jenoptik AG to Report Q1, 2022 Results on May 11, 2022

Is It Time To Consider Buying Jenoptik AG (ETR:JEN)?

Now 21% undervalued

Investor sentiment improved over the past week

Jenoptik AG (XTRA:JEN) completed the acquisition of BG Medical Applications GmbH, SwissOptic AG and SwissOptic (Wuhan) Co., Ltd. from Berliner Glas KGaA Herbert Kubatz GmbH & Co.

Fund managed by STAR Capital Partnership LLP agreed to acquire VINCORION from Jenoptik AG (XTRA:JEN).

Third quarter 2021 earnings released: EPS €0.46 (vs €0.24 in 3Q 2020)

Is Jenoptik (ETR:JEN) Using Too Much Debt?